Dr Ndaba Mazibuko

Care Oncology Clinic, Kings College London

Dr Ndaba Mazibuko is a Clinical Research Fellow in Clinical Neuroscience (Institute of Psychiatry, Psychology and Neuroscience - King''s College London). His work includes clinical trial design, management and data analysis with respect to pharmacological and neuro-imaging studies in both the academic and industry sectors. For the last three years he has also collaborated with the SEEK GROUP and The Care Oncology Clinic in the area of Metabolic Repurposed Drug Analysis and Novel Vaccine Development, with respect to both scientific research and direct clinical application.

His academic position includes medical student clinical rotation tutoring and periodic lectures for Kings College London. Prior to that he was a Neurology and Acute Stroke Registrar at King''s College Hospital and has several years’ experience as a clinician in varied disciplines within the NHS in addition to clinical experience in Australia (where he trained) and also in Africa.

dont miss

Drug Repurposing In Practice: Metabolic Pleiotropism in Glioblastoma Management

Care Oncology Clinic (COC) has been set up to enable the use of off-label drugs by Physicians to treat cancer patients as an adjunct to their standard of care. COC has developed a protocol which comprises a combination of four generic metabolic modulating medicines. These medicines have excellent safety profiles and well-established anti-cancer effects in pluralistic peer-review literature. COC’s analysis seeks to contribute to this emerging data.

EVEN MORE SEMINARS

  • Philip Beer MRCP, FRCPath, PhD: Speaking at the Oncology Convention

    Philip Beer MRCP, FRCPath, PhD
    ONCODNA S.A

    The evolution of oncology therapeutics in the genomic era.

  • Prof Adam Waldman: Speaking at the Oncology Convention

    Prof Adam Waldman
    MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

    Biomarkers in Adult Glioma

  • Mr Naga Venkatesh Jayanthi MD, FRCS: Speaking at the Oncology Convention

    Mr Naga Venkatesh Jayanthi MD, FRCS
    Bupa - Consultant Surgeon

    Minimal Invasive Oesophagectomy – where are we going?

  • Michael Schreiber: Speaking at the Oncology Convention

    Michael Schreiber
    Brain Tumor Foundation, Chairman

    Brain Tumors - Innovation, support and advocacy

  • Merina Ahmed: Speaking at the Oncology Convention

    Merina Ahmed
    Royal Marsden NHS foundation Trust

    Stereotactic Radiotherapy for lung tumours and oligometastatic disease